Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 16Vaginal Neoplasms 3Gliosarcoma 2Glioblastoma 2Endometrial Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Vulvar Neoplasms 1Small Cell Lung Carcinoma 1Retinoblastoma 1Prostatic Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Adenocarcinoma 1Abdominal Malignancy 1

Interventions

Papillomavirus Vaccines 5human papillomavirus vaccine, L1 type 16, 18 2Vaccines 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2halofantrine 1fludarabine 1VGX-3100 1Radiotherapy 1Polymerase Chain Reaction 1Interleukin-2 1Interferon alpha-2 1Cyclophosphamide 1Cidofovir 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Papillomavirus Infections × Brachytherapy × Clear all
NCT00811408 2010-01-28

Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

National Cancer Institute (NCI)

Phase 1 Unknown
24 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡